… When available, NS5A resistance can have important clinical implications for treatment-naive
and -experienced individuals with HCV infection. NS5A resistance testing is recommended …

… resistance to anticancer therapies. Furthermore, we report on the role of TME-mediated
intratumor metabolic heterogeneity in drug resistance and the reliance of many therapy-resistant …

… Consequences of drug resistance range from toxicity inherent in use of second-line …
the mechanisms, implications, and management of resistance to antiviral drugs used to treat …

… limited by the development of drug resistance. Such acquired resistance is driven, in part, …
a possible mechanistic basis for anticancer drug resistance. In fact, accumulating evidence …

… isolates often contain multiple resistance mutations. A limitation of genotypic assays is that
… drug resistance and risk factors Much of our existing knowledge about CMV drug resistance …

… resistance-associated mutations in drugs for which there is poor or unproven correlation
between phenotypic and clinical drug resistance … of drug resistance, the clinical implications of …

… Some also exhibit great potential as novel biomarkers for predicting drug response to …
of drug resistance in GC progression. We also highlight the potential of drug resistance-related …

… However, the frequency of cross-resistance and the development of resistance to fJ-lactams …
, many clinicians are not generally aware of the clinical implications of cross-resistance. Addi…

… that are known to confer resistance. Here we present molecular insights into the mechanisms
for aspirin and clopidogrel resistance, with a discussion of their clinical implications. …

… drug resistance in CRC. Certain of these miRNAs may thus be used as promising biomarkers
for predicting drug … We also discuss the potential role of drug resistance-related miRNAs as …